ENDRA Life Sciences (NDRA) Asset Utilization Ratio (2017 - 2018)
ENDRA Life Sciences (NDRA) reported Asset Utilization Ratio of 0.0 for Q4 2018, down 97.19% year-over-year from 0.05 in Q4 2017, and down 75.85% quarter-over-quarter from 0.01 in Q3 2018.
ENDRA Life Sciences (NDRA) Asset Utilization Ratio (2017 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has 2 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2018.
- Asset Utilization Ratio for Q4 2018 came in at 0.0, down 97.19% year-over-year; the trailing twelve-month figure through Dec 2018 was 0.0 (down 97.19% YoY), and the FY2018 annual result was 0.0, down 99.13% from the prior year.
- Asset Utilization Ratio fell to 0.0 in Q4 2018 per NDRA's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.14 in Q2 2017 and troughed at 0.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 0.25 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 0.40 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 0.30 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 1.32 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 0.56 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 1.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 0.56 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 0.67 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 1.11 |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.09 |
| Mar 31, 2018 | 0.07 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.11 |
| Jun 30, 2017 | 0.14 |